Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors
Jian Liang1, Richard E. Moore2, Eric D. Moher3, John E. Munroe3, Rima S. Al-awar3, David A. Hay3, David L. Varie3, Tony Y. Zhang3, James A. Aikins3, Michael J. Martinelli3, Chuan Shih3, James E. Ray3, Lowell L. Gibson3, Vasu Vasudevan3, Lisa Polin4, 5 Contact Information, Kathryn White4, Juiwanna Kushner4, Chiab Simpson4, Susan Pugh4 and Thomas H. Corbett4
Investigational New Drugs
Volume 23, Number 3 / June 2005 г., Pages 213-224
DOI:
Код: Выделить всё
http://dx.doi.org/10.1007/s10637-005-6729-9 